Alexza Pharma (ALXA) Reports Q4 Loss of $0.15/Share; Warns it May Shut Down
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Alexza Reports Fourth Quarter and Year End 2015 Financial Results
March 28, 2016 4:10 PM EDTMOUNTAIN VIEW, Calif., March 28, 2016 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA, "Alexza", or the "Company") today reported financial results for the quarter and year ended December 31, 2015. The net loss for the fourth quarter was $3.0 million compared to $6.7 million during the same quarter in 2014. The net loss for the years ended December 31, 2015 and 2014 was $21.3 million and $36.7 million, respectively. At December 31, 2015, Alexza had consolidated cash and cash equivalents of $7.8 million.
"We continue our efforts to increase the value of ADASUVE, our pipeline and of Alexza," said Thomas B. King, President and CEO of Alexza Pharmaceuticals. "In... More
